[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Several other obesity catalysts remain for the year the could indirectly impact $VKTX $LLY $NVO. Biggest is Lilly Trump deal that could redefine the whole sector Lilly retatrutide phase X in OS. I doubt it will look as clean as from AEs some may expect . but will add OA as another GLP1 massive indication that Medicare cant ignore Several other phase X trials from $AZN $GPCR $NVO ( amycretin in T2D) Roche $TERN $AMGN and others. And obesity M&A news could emerge any day or not this year"
X Link @bioinvestor24 2025-10-13T19:03Z 4374 followers, 5334 engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $ALT Phase 2b $ALEC Phase X $ADVM Phase X $ZBIO Phase X $PCVX Phase X $RARE Phase X $TRAW Phase X $GPCR Phase 2b $SLS Phase X $RHHBY Phase X $MREO Phase X $KMDA Phase X $INSM Phase X $ATOS Phase X $ARTV Phase 2a $ALZN Phase X $AGIO Phase X $ADCT Phase X $TLPH Phase X $STOK Phase X $RLMD Phase X $REGN Phase 2/3 $PBYI Phase X $PBYI Phase X $NVS Phase X $NAMS Phase X $NAMS Phase X $NAMS Phase X $MRNA Phase X $INKT Phase X $LSTA Phase 2b $KZIA Phase X $JAZZ Phase X $IONS Phase X $INAB Phase X $IMMP Phase 2/3 $GNFT Phase X $FBIO"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.4K followers, XXX engagements
"@2000STOCKMASTER I used to like $GPCR but Attain X screwed all small molecules. Orforglipron has the best PK and best early clinical data and still disappointed Structure drug has big derisking event soon that could killed it or make it"
X Link @bioinvestor24 2025-10-12T00:06Z 4374 followers, XXX engagements
"@bioinvestor24 sont forget $gpcr under thevradar and a major takeover candidate"
X Link @2000STOCKMASTER 2025-10-11T23:33Z 1939 followers, XXX engagements